Logo

Eksigent Nabs $2 Million ATP Grant from NIS

Sep 11, 2003

NEW YORK, Sept. 11 (GenomeWeb News) - Microfluidics company Eksigent Technologies won a $2 million grant from the National Institute of Standards and Technology's Advanced Technology Program, the firm said today.

 

The grant will help fund the company's ChipLC system, which is being designed to enable researchers to use high performance liquid chromatography and perform highly parallel chip-based chemical analysis.

The ATP funding will be used for a 3-year development program. Eksigent expects to commercialize intermediate-stage chip-based products during the three years.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.